Erratum: 12/15-Lipoxygenase Inhibition Reverses Cognitive Impairment, Brain Amyloidosis, and Tau Pathology by Stimulating Autophagy in Aged Triple Transgenic Mice (Biological Psychiatry (2017) 81(2) (92–100), (S0006322316324283), (10.1016/j.biopsych.2016.05.023));12/15-Lipoxygenase Inhibition Reverses Cognitive Impairment, Brain Amyloidosis, and Tau Pathology by Stimulating Autophagy in Aged Triple Transgenic Mice

Biological Psychiatry

Volumn 81, Issue 2, 2017, Pages 92-100

  Di Meco, Antonio ^a   Li, Jian Guo ^a   Blass, Benjamin E ^b   Abou Gharbia, Magid ^b   Lauretti, Elisabetta ^a   Praticò, Domenico ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

12 15 Lipoxygenase; Alzheimer's disease; Amyloid beta; Animal model; Autophagy; Tau protein

Indexed keywords

6,11 DIHYDRO 5 THIA 11 AZA BENZO[A] FLUORENE; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; AUTOPHAGY RELATED PROTEIN 5; AUTOPHAGY RELATED PROTEIN 7; NICASTRIN; OXYGENASE INHIBITOR; PLACEBO; PRESENILIN 1; PRESENILIN 2; UNCLASSIFIED DRUG; 12-15-LIPOXYGENASE; 6,11-DIHYDRO-5-THIA-11-AZA-BENZO(A)-FLUORENE; FLUORENE DERIVATIVE; MAPT PROTEIN, MOUSE; TAU PROTEIN;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; BRAIN HOMOGENATE; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME INHIBITION; EX VIVO STUDY; IN VITRO STUDY; LEARNING DISORDER; MEMORY DISORDER; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; TAU NEUROPATHOLOGY; TRANSGENIC MOUSE; ALZHEIMER DISEASE; ANIMAL; BRAIN; CONDITIONED REFLEX; DRUG EFFECTS; ENCEPHALITIS; ENZYMOLOGY; FEAR; METABOLISM; PHYSIOLOGY; PSYCHOLOGY; RECALL; SYNAPSE; TUMOR CELL CULTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; AUTOPHAGY; BRAIN; COGNITIVE DYSFUNCTION; CONDITIONING, CLASSICAL; ENCEPHALITIS; FEAR; FLUORENES; MENTAL RECALL; MICE; MICE, TRANSGENIC; SYNAPSES; TAU PROTEINS; TUMOR CELLS, CULTURED;

EID: 84999791314     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2024.04.002     Document Type: Erratum

References (23)

1. 1 Alzheimer's Association. 2015 Alzheimer's disease facts and figures. Alzheimers Dement 11 (2015), 332–384.
2. 2 Uderhardt, S., Krönke, G., 12/15-lipoxygenase during the regulation of inflammation, immunity, and self-tolerance. J Mol Med (Berl) 90 (2012), 1247–1256.
3. 3 Giannopoulos, P.F., Joshi, Y.B., Praticò, D., Novel lipid signaling pathways in Alzheimer disease pathogenesis. Biochem Pharmacol 88 (2014), 560–564.
4. 4 Praticò, D., Zhukareva, V., Yao, Y., Uryu, K., Funk, C.D., Lawson, J.A., et al. 12/15-lipoxygenase is increased in Alzheimer's disease: Possible involvement in brain oxidative stress. Am J Pathol 164 (2004), 1655–1662.
5. 5 Yao, Y., Clark, C.M., Trojanowski, J.Q., Lee, V.M., Praticò, D., Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment. Ann Neurol 58 (2005), 623–626.
6. 6 Yang, H., Zhuo, J., Chu, J., Chinnici, C., Praticò, D., Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase. Biol Psychiatry 68 (2010), 922–929.
7. 7 Succol, F., Praticò, D., A role for 12/15-Lipoxygenase in the amyloid β precursor protein metabolism. J Neurochem 104 (2007), 380–387.
8. 8 Bocan, T.M., Rosebury, W.S., Mueller, S.B., Kuchera, S., Welch, K., Daugherty, A., et al. A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in rabbits. Atherosclerosis 136 (1998), 203–216.
9. 9 Chen, Y., Peng, C., Abraham, S.A., Shan, Y., Guo, Z., Desouza, N., et al. Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival. J Clin Invest 124 (2014), 3847–3862.
10. 10 Di Meco, A., Joshi, Y.B., Lauretti, E., Praticò, D., Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice. Mol Psychiatry 21 (2016), 403–410.
11. 11 Di Meco, A., Lauretti, E., Vagnozzi, A.N., Praticò, D., Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer's disease mice. Neurobiol Aging 35 (2014), 2458–2464.
12. 12 Li, J.-G., Chu, J., Barrero, C., Merali, S., Praticò, D., Homocysteine exacerbates Aβ, tau pathology and cognitive deficit in a mouse model of Alzheimer's with plaques and tangles. Ann Neurol 75 (2014), 851–863.
13. 13 Chu, J., Li, J.-G., Joshi, Y.B., Giannopoulos, P.F., Hoffman, N.E., Madesh, M., et al. Gamma secretase-activating protein is a substrate for caspase-3: Implications for Alzheimer's disease. Biol Psychiatry 77 (2015), 720–728.
14. 14 Chu, J., Li, J.G., Hoffman, N.E., Madesh, M., Praticò, D., Degradation of gamma secretase activating protein by the ubiquitin-proteasome pathway. J Neurochem 133 (2015), 432–439.
15. 15 Barth, S., Glick, D., Macleod, K.F., Autophagy: Assays and artifacts. J Pathol 221 (2010), 117–124.
16. 16 Zhang, Y., Liao, Z., Zhang, L.J., Xiao, H.T., The utility of chloroquine in cancer therapy. Curr Med Res Opin 31 (2015), 1009–1013.
17. 17 Chu, J., Zhuo, J.M., Praticò, D., Transcriptional regulation of β-secretase-1 by 12/15-lipoxygenase results in enhanced amyloidogenesis and cognitive impairments. Ann Neurol 71 (2012), 57–67.
18. 18 Chu, J., Li, J.G., Giannopoulos, P.F., Blass, B.E., Childers, W., Abou-Gharbia, M., et al. Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, Aβ and tau neuropathology in the triple-transgenic mice. Mol Psychiatry 20 (2015), 1329–1338.
19. 19 Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39 (2003), 409–421.
20. 20 Phillips, R.G., LeDoux, J.E., Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106 (1992), 274–285.
21. 21 Joshi, Y., Giannopoulos, P.F., Praticò, D., The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease. Trends Pharmacol Sci 36 (2015), 181–186.
22. 22 Jang, I., Park, S., Cho, J.W., Yigitkanli, K., van Leyen, K., Roth, J., Genetic ablation and short-duration inhibition of lipoxygenase results in increased macroautophagy. Exp Cell Res 321 (2014), 276–287.
23. 23 Morgan, A.H., Hammond, V.J., Sakoh-Nakatogawa, M., Ohsumi, Y., Thomas, C.P., Blanchet, F., et al. A novel role for 12/15-lipoxygenase in regulating autophagy. Redox Biol 4 (2015), 40–47.